Series B - Tridiuum

Series B - Tridiuum

Investment Firm

Overview

Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.

Announced Date

Dec 18, 2018

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Sopris Capital Associates

Sopris Capital Associates

Sopris Capital Associates is a early_stage_venture and post_ipo and venture firm.

Participant Investors

4

Investor Name
Participant InvestorSopris Capital Associates
Participant InvestorFresenius Medical Care
Participant InvestorBen Franklin Technology Partners of Southeastern Pennsylvania
Participant InvestorSilicon Valley Bank

Round Details and Background

Tridiuum raised $9500000 on 2018-12-18 in Series B

Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 18, 2018
Series B - Tridiuum
5-9.5M

Recent Activity

There is no recent news or activity for this profile.